EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunohistochemical p16 overexpression and Rb loss correlate with high‐risk human papillomavirus infection in endocervical adenocarcinomas

Nobuko Yasutake iD, Hidetaka Yamamoto iD, Ryosuke Kuga, Rina Jiromaru iD, Takahiro Hongo iD, Yoshihiro Katayama, Kenzo Sonoda iD, Hideaki Yahata iD, Kiyoko Kato, Yoshinao Oda iD

Histopathology · 2024

DOI: 10.1111/his.15169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2024. Verfasst von Nobuko Yasutake und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, Cyclin-Dependent Kinase Inhibitor p16, Adenocarcinoma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims p16 is a sensitive surrogate marker for transcriptionally active high‐risk human papillomavirus (HR‐HPV) infection in endocervical adenocarcinoma (ECA); however, its specificity is not perfect. Methods and results We examined p16 and Rb expressions by immunohistochemistry (IHC) and the transcriptionally active HR‐HPV infection by mRNA in‐situ hybridisation (ISH) with histological review in 108 ECA cases. Thirteen adenocarcinomas of endometrial or equivocal origin (six endometrioid and seven serous carcinomas) were compared as the control group. HR‐HPV was detected in 83 of 108 ECA cases (77%), including five HPV‐associated adenocarcinomas in situ and 78 invasive HPV‐associated adenocarcinomas. All 83 HPV‐positive cases showed consistent morphology, p16 positivity and partial loss pattern of Rb. Among the 25 cases of HPV‐independent adenocarcinoma, four (16%) were positive for p16, and of these four cases, three of 14 (21%) were gastric type adenocarcinomas and one of 10 (10%) was a clear cell type adenocarcinoma. All 25 HPV‐independent adenocarcinomas showed preserved expression of Rb irrespective of the p16 status. Similarly, all 13 cases of the control group were negative for HR‐HPV with preserved expression of Rb, even though six of 13 (46%) cases were positive for p16. Compared with p16 alone, the combination of p16 overexpression and Rb partial loss pattern showed equally excellent sensitivity (each 100%) and improved specificity (100 versus 73.6%) and positive predictive values (100 versus 89.2%) in the ECA and control groups. Furthermore, HR‐HPV infection correlated with better prognosis among invasive ECAs. Conclusions The results suggest that the combined use of p16 and Rb IHC could be a reliable method to predict HR‐HPV infection in primary ECAs and mimics. This finding may contribute to prognostic prediction and therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsUterine Cervical NeoplasmsCyclin-Dependent Kinase Inhibitor p16AdenocarcinomaImmunohistochemistryBiomarkers, TumorHumansFemaleMiddle AgedAdultAgedRetinoblastoma ProteinIn Situ HybridizationPapillomaviridae

Stichwörter der Autor:innen

Rbendocervical adenocarcinomahuman papillomavirusp16uterus

Substanzen

Cyclin-Dependent Kinase Inhibitor p16Biomarkers, TumorRetinoblastoma ProteinCDKN2A protein, human

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Gynecology and Obstetrics, Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan.
  • Department of Pathology, Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama University, Okayama, Japan.
  • Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Gynecology and Obstetrics, National Kyushu Cancer Center, Fukuoka, Japan.

ORCID-Profile: Nobuko Yasutake, Hidetaka Yamamoto, Rina Jiromaru, Takahiro Hongo, Kenzo Sonoda, Hideaki Yahata, Yoshinao Oda

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yasutake, N., Yamamoto, H., Kuga, R., Jiromaru, R., Hongo, T., Katayama, Y., Sonoda, K., Yahata, H., Kato, K., & Oda, Y. (2024). Immunohistochemical p16 overexpression and Rb loss correlate with high‐risk human papillomavirus infection in endocervical adenocarcinomas. Histopathology. https://doi.org/10.1111/his.15169

Vancouver

Yasutake N, Yamamoto H, Kuga R, Jiromaru R, Hongo T, Katayama Y, et al. Immunohistochemical p16 overexpression and Rb loss correlate with high‐risk human papillomavirus infection in endocervical adenocarcinomas. Histopathology. 2024. doi:10.1111/his.15169

BibTeX
@article{Yasutake2024,
  author = {Yasutake, Nobuko and Yamamoto, Hidetaka and Kuga, Ryosuke and Jiromaru, Rina and Hongo, Takahiro and Katayama, Yoshihiro and Sonoda, Kenzo and Yahata, Hideaki and Kato, Kiyoko and Oda, Yoshinao},
  title = {Immunohistochemical p16 overexpression and Rb loss correlate with high‐risk human papillomavirus infection in endocervical adenocarcinomas},
  journal = {Histopathology},
  year = {2024},
  doi = {10.1111/his.15169}
}
Kostenlos starten →